(Q37992849)

26 August 2017

The interferons and their receptors--distribution and regulation (English)

1 reference

26 August 2017

Nicole A de Weerd

1

0 references

author name string

Thao Nguyen

series ordinal

2

1 reference

PubMed ID

22410872

26 August 2017

language of work or name

1 reference

13 March 2012

1 reference

Immunology & Cell Biology

26 August 2017

1 reference

26 August 2017

90

1 reference

26 August 2017

483-491

1 reference

26 August 2017

5

1 reference

Virus interference. I. The interferon

26 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interferons, interferon-like cytokines, and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The interferons: 50 years after their discovery, there is much more to learn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Full house: 12 receptors for 27 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Ligand-induced association of the type I interferon receptor components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IL-6 transsignaling: the in vivo consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Shared receptor components but distinct complexes for alpha and beta interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Stochastic receptor expression determines cell fate upon interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The IFN gamma receptor: a paradigm for cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interferon-lambda: a new addition to an old family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IFNgamma signaling-does it mean JAK-STAT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The yin and yang of type I interferon activity in bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Beta interferon suppresses the development of experimental cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Role of type I IFNs in pulmonary complications of Pneumocystis murina infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Type I interferon (IFN-alpha/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Role of type I interferons in the activation of autoreactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Modulation of T-cell function by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Direct effects of type I interferons on cells of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Type I interferon response in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Regulation of interferon-gamma during innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Lambda interferon inhibits hepatitis B and C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Ligand-independent pathway that controls stability of interferon alpha receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interfering with interferon receptor sorting and trafficking: impact on signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Biochemical monitoring of the early endocytic traffic of the type I interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

TYK2 activity promotes ligand-induced IFNAR1 proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Toll-like receptor 2 stimulation decreases IFN-gamma receptor expression in mouse RAW264.7 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

West Nile virus infection induces depletion of IFNAR1 protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Encoding of a homolog of the IFN-gamma receptor by myxoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.9

IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression

21 January 2018

1 reference

12 December 2020

Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity

1 reference

12 December 2020

Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster

1 reference

12 December 2020

Inhibition of interferon-gamma signaling by Leishmania donovani

1 reference

12 December 2020

Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement

1 reference

12 December 2020

The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells

1 reference

12 December 2020

Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis

1 reference

12 December 2020

Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes

1 reference

12 December 2020

Role of beta interferon in resistance to Toxoplasma gondii infection

1 reference

12 December 2020

Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells

1 reference

12 December 2020

Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.

1 reference

12 December 2020

Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes

1 reference

12 December 2020

STAT activation and differential complex formation dictate selectivity of interferon responses

1 reference

12 December 2020

p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.

1 reference

12 December 2020

Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones

1 reference

12 December 2020

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains

1 reference

12 December 2020

Identifiers

DOI

10.1038/ICB.2012.9

1 reference

26 August 2017

0 references

1 reference

PubMed ID

22410872